Composition, form of production and packaging
? The tablets covered with a cover 1 tab.
Inositol 25 mg
cyanocobalamin not less than 1.5 Ојg
liver extract KPC N (liver hydrolyzate) 70 mg containing
choline hydrotartrate 100 mg
cysteine вЂ‹вЂ‹16.57 mg
cysteine вЂ‹вЂ‹hydrochloride 21.5 mg,
50 pcs. - bottles of dark glass (1) - packs of cardboard.
20 pcs. - bottles of dark glass (1) - packs of cardboard.
100 pieces. - bottles of dark glass (1) - packs of cardboard.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2010.
Preparation Progepar contributes to the preservation and restoration of the structure of hepatocytes, inhibits the formation of connective tissue in the liver, promotes the regeneration of that part of the parenchyma. which was destroyed. Progepar also helps improve local blood flow in the liver tissue, increases diuresis and improves the functional performance of the liver.
- complex therapy for chronic hepatitis;
- fatty degeneration of liver of various genesis;
- toxic hepatitis including alcoholic;
- cirrhosis of the liver;
- Hepatopathy of various genesis;
- drug intoxication;
- radiation sickness;
- the time of the course of therapy with cytostatics;
If the doctor does not prescribe a different treatment regimen, then the drug is taken 1-2 tablets three times a day daily, swallowing it whole, without chewing, and squeezed with enough liquid. The course of treatment is individual.
Allergic reactions are possible.
hypersensitivity to the components of the drug.
APPLICATION FOR CHILDREN
Contraindicated in childhood.
TERMS OF RELEASE FROM PHARMACY
The drug is released by prescription.
TERMS AND CONDITIONS OF STORAGE
At a temperature of no higher than 25 В° C, in a dry, protected from light and out of reach of children. Shelf life - 3 years.